The Atrium Building at The University of Suffolk was built in the 1960’s and required a full refurbishment and modernisation to provide a new innovation centre dedicated to STEM subjects.
What Did The Job Involve?
The works included alterations and refurbishment of the existing Atrium (West Building), associated external works, and a new plant room extension. The external fabric of the building was given a makeover completely transforming it from the 60’s style to a modern teaching facility. This included replacing the windows, doors, curtain walling, over-cladding the existing brick façade to improve thermal performance, and extending the existing brise soleil.
Internally the existing atrium was given a makeover with improved lighting, comfort cooling and a new passenger lift serving the three floor levels. Existing rooms over three storeys were reconfigured to provide modern new teaching facilities now housing state of the art equipment including a 3D radiotherapy device, design hubs, and a 120-seater lecture theatre all surrounding an impressive café and social space.
What Were The Challenges?
The date for practical completion was set in stone from the start, as the building was due to open for the start of the new academic year. As with any refurbishment project, there were some unforeseen challenges along the way, therefore Beardwell Construction had to collaborate closely with the client, Bond Bryan Architects, Castons, and the M&E Consultant, JSH to ensure that the programme was not affected. Beardwell Construction successfully completed the project on time, enabling the University to open the new facility as planned.
Beardwell’s Added Value
Whilst completing the works on site, Beardwell Construction organised several site tours for students of the University. We also carried out some access improvements to further help the client. Beardwell are also proud to have donated labour and materials to the nearby Eden Rose community project to help transform a piece of neglected woodland into a nature area for people with terminal illnesses.
